ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis (RA) and synovitis"

  • Abstract Number: 304 • 2018 ACR/ARHP Annual Meeting

    Dynamic MRI in Rheumatoid Arthritis for the Assessment of Synovitis Promoting Cartilage Loss

    Philipp Sewerin1, Anja Mueller-Lutz2, Matthias Schneider3, Christoph Schleich4, Benedikt Ostendorf1 and Stefan Vordenbäumen5, 1Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Düsseldorf, Germany, 2Department for diagnostic and interventional Radiology, Heinrich-Heine University, Düsseldorf, Germany, 3Department and Hiller-Research-Unit for Rheumatology, Heinrich-Heine University, Duesseldorf, Germany, 4Department for diagnostic and interventional Radiology, Heinrich-Heine University, Duesseldorf, Germany, 5Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Düsseldorf, Germany

    Background/Purpose: To investigate the local inflammatory activity of the synovium by using dynamic magnetic resonance imaging (MRI) and cartilage biochemical composition of the MCP-joints 2…
  • Abstract Number: 928 • 2018 ACR/ARHP Annual Meeting

    Single Cell RNA-Sequencing of Rheumatoid Synovial Fibroblasts Reveals a Disease-Associated Spatial Gradient Modulated By Inductive Notch Signaling

    Kevin Wei1, Ilya Korsunsky2, Jennifer Marshall3, Gerald Watts4, Anqi Gao5, Philip Blazar6, Jeffrey Lange6, Thomas Thornhill6, Chris Buckley7, Soumya Raychaudhuri8 and Michael Brenner9, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 4Brigham and Women's Hospital, Boston, MA, 5Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 6Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 7University of Birmingham, Birmingham, United Kingdom, 8Medical and Population Genetics Program, Broad Institute of MIT and Harvard, Cambridge, MA, 9Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: In rheumatoid arthritis (RA), tissue resident fibroblasts orchestrate chronic inflammation and regulate pathologic bone and cartilage remodeling that causes irreversible joint damage. Recently, we…
  • Abstract Number: 1930 • 2018 ACR/ARHP Annual Meeting

    Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Rheumatoid Arthritis Patients in Clinical Remission

    Dana Orange1, Phaedra Agius2, Edward F. DiCarlo3, Serene Z. Mirza4, Cristina Rozo5, Tania Pannellini5, Mark P. Figgie6, William H. Robinson7, Jackie Szymonifka5, Vivian P. Bykerk5, Laura T. Donlin8 and Susan M. Goodman5, 1Rockefeller University, New York, NY, 2New York Genome Center, New York, NY, 3Laboratory Medicine, Hospital for Special Surgery, New York, NY, 4Rheumatology, Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, New York, NY, 6Surgery, Hospital for Special Surgery, New York, NY, 7Stanford University, Palo Alto, CA, 8Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

    Background/Purpose:   Rheumatoid Arthritis (RA) patients in clinical remission may still develop structural damage that has been attributed to ongoing synovial inflammation, sometimes only detectable…
  • Abstract Number: 2473 • 2018 ACR/ARHP Annual Meeting

    The Relation between Inflammatory Joint Activity and Disability Related to the Lower Extremities in Early Rheumatoid Arthritis

    Maria Mellblom Bengtsson1,2, Sofia Hagel3, Lennart Jacobsson4 and Carl Turesson1,2, 1Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, 2Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, 3Rheumatology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

     Background/Purpose: Arthritis in the lower extremities has a major impact in many patients in rheumatoid arthritis (RA), but has not been extensively studied. The objective…
  • Abstract Number: 970 • 2017 ACR/ARHP Annual Meeting

    ACPA Activate Challenged Synovial Fibroblasts through a PAD Dependent Mechanism: A Potential Explanation of the “Second Hit Model” in RA

    Meng Sun1, Vijay Joshua1, Akilan Krishnamurthy1, Aase Hensvold1, Yanying Liu2, Sergiu-Bogdan Catrina3, Caroline Ospelt4, Vivianne Malmström1, Johanna Steen1, Marianne Engström1, Heidi Wähämaa1, Bence Rethi1 and Anca I. Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Peking University People's Hospital, Beijing, China, 3Molecular Medicine and Surgery, Molecular Medicine and Surgery, Stockholm, Sweden, 4Center of Experimental Rheumatology, University Hospital Zürich, Zurich, Switzerland

    Background/Purpose: Anti-citrullinated proteins antibodies (ACPAs) injected in mice induce IL-8 dependent bone loss and arthralgia, but no synovial changes. We hypothesized that additional stimulus, sensitizing…
  • Abstract Number: 1405 • 2017 ACR/ARHP Annual Meeting

    Using Flow and Mass Cytometry to Demonstrate Robust Tissue Processing to Query Molecular Heterogeneity in Phase 1 of the Accelerating Medicines Partnership (AMP) – RA Network

    Kevin Wei1, Deepak Rao2, Fan Zhang3, Chamith Fonseka3, Kamil Slowikowski3, Joshua Keegan4, Laura T. Donlin5, Jason Turner6, Mandy J. McGeachy7, Nida Meednu8, David Lieb9, Stephen Kelly10, Susan M. Goodman11, David L. Boyle12, William H. Robinson13, Paul J. Utz14, Gary S. Firestein15, Harris Perlman16, Edward F. DiCarlo17, Costantino Pitzalis10, Andrew Filer18, Brendan Boyce19, Ellen M. Gravallese20, Chad Nusbaum21, James Lederer4, Nir Hacohen22,23,24, Peter Gregersen25, Larry W. Moreland26, Michael Holers27, Vivian P. Bykerk28, Soumya Raychaudhuri3, Michael Brenner29 and Jennifer H. Anolik8, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 3Divisions of Genetics and Rheumatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 4Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 5Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 6Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 7Medicine, University of Pittsburgh, Pittsburgh, PA, 8Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 9Broad Institute, Cambridge, MA, 10Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 11Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 12University of California San Diego, La Jolla, CA, 13Stanford University School of Medicine, Stanford, CA, 14Medicine, Stanford University School of Medicine, Stanford, CA, 15Medicine, University of California San Diego, La Jolla, CA, 16Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University Feinberg School of Medicine,, Chicago, IL, 17Laboratory Medicine, Hospital for Special Surgery, New York, NY, 18Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 19University of Rochester Medical Center, Rochester, NY, 20Lazare Research Bldg, University of Massachusetts Medical School, Worcester, MA, 21The Broad Institute and Harvard, Cambridge, MA, 22Harvard Medical School, Boston, MA, 23Massachusetts General Hospital, Charlestown, MA, 24Broad Institute of MIT and Harvard, Cambridge, MA, 25The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 26Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 27Medicine, Division of Rheumatology, University of Colorado Denver, Aurora, CO, 28Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 29Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Discovery and application of new therapies for rheumatoid arthritis (RA) has been hampered by multiple factors, including disease heterogeneity and the lack of well…
  • Abstract Number: 1416 • 2017 ACR/ARHP Annual Meeting

    Higher Expression of Type 1 Interferon in Synovitis of Patient with Undifferentiated Arthritis before They Met Rheumatoid Arthritis Criteria Compared to Established Rheumatoid Arthritis.  a Retrospective Study with 14 Years of Follow-up

    Andrea Cuervo1, Raquel Celis2, Julio Ramírez3, Alicia Usategui4, Regina Faré5, M. Victoria Hernández6, Virginia Ruiz-Esquide3, Jose Inciarte-Mundo7, Raimon Sanmarti8, Jose L. Pablos9 and Juan D. Cañete7, 1Arthritis Unit. Rheumatology Dpt, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain, 2Arthritis Unit, Rheumatology Department, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona and IDIBAPS, Barcelona, Spain, 3Rheumatology Service, Hospital Clínic de Barcelona, Barcelona, Spain, 4Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 5Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 6Hospital Clinic. Barcelona. Spain, Barcelona, Spain, 7Rheumatology Department, Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona, Barcelona, Spain, 8Arthritis Unit, Rheumatology Dpt, Hospital Clinic of Barcelona, Barcelona, Spain, 9Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain

    Background/Purpose: Undifferentiated Arthritis (UA) is defined as an inflammatory oligo/poly arthritis that does not fulfil criteria for a definitive diagnosis.Delay in diagnosis and treatment leads…
  • Abstract Number: 1898 • 2017 ACR/ARHP Annual Meeting

    Overweight/Obesity Affect Histological Features of Synovial Membrane of Rheumatoid Arthritis Patients from Disease Onset to Stable Remission Achievement

    Stefano Alivernini1, Barbara Tolusso1, Maria Rita Gigante1, Laura Bui2, Clara Di Mario1, Luca Petricca1, Gabriele Di Sante1, Roberta Benvenuto2, Anna Laura Fedele1, Francesco Federico2, Gianfranco Ferraccioli3 and Elisa Gremese1, 1Institute of Rheumatology, Fondazione Policlinico Universitario A. Gemelli - Catholic University of the Sacred Heart, Rome, Italy, 2Institute of Pathology, Fondazione Policlinico Universitario A. Gemelli - Catholic University of the Sacred Heart, Rome, Italy, 3Institute of Rheumatology, Università Cattolica - Fondazione Policlinico Universitario A.Gemelli, Rome, Italy

    Background/Purpose: Despite animal models, little is known about synovial tissue (ST) composition of overweight/obese Rheumatoid Arthritis patients. The aim of the study was to investigate…
  • Abstract Number: 2567 • 2016 ACR/ARHP Annual Meeting

    The Effect of Fibroblast Growth Factor 4 on the Proliferation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis

    Xiaoxue Feng1, Shangling Zhu1, Weixiang Peng2, Fang Liu3, Baiyu Zhang1 and Jianlin Huang1, 1Department of Internal Medicine, Division of Rheumatology, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, 2Department of Internal Medicine, Division of Rheumatology, Zhu Hai People's Hospital, Zhuhai, China, 3Department of Internal Medicine, Division of Rheumatology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Background/Purpose:  Fibroblast-like synoviocytes (FLSs) contribute to synovial hyperplasia in rheumatoid arthritis (RA). Fibroblast growth factor 4 (FGF4) is a potent mitogen for tumor cells. The…
  • Abstract Number: 537 • 2015 ACR/ARHP Annual Meeting

    The Course of Bone Marrow Edema in Early Undifferentiated and Rheumatoid Arthritis; A Longitudinal MRI Study on Bone Level

    W.P. Nieuwenhuis1, H.W. van Steenbergen2, W. Stomp3, T. Stijnen4, T. W. J. Huizinga1, J.L Bloem3, D. van der Heijde1, M. Reijnierse3 and A.H.M. van der Helm- van Mil2, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Medical Statistics, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: In rheumatoid arthritis (RA) patients, bone marrow edema (BME)-scores are associated with development of erosions. However, little is known on the course and outcome…
  • Abstract Number: 1607 • 2015 ACR/ARHP Annual Meeting

    Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner

    Chikashi Terao1, Noriyuki Yamakawa2, Koichiro Yano3, I.M. Markusse4, Katsunori Ikari3, Shinji Yoshida3, Moritoshi Furu5, Motomu Hashimoto5, Hiromu Ito5, Takao Fujii6, Koichiro Ohmura7, Kosaku Murakami7, Meiko Takahashi2, Masahide Hamaguchi8, Yasuharu Tabara2, Atsuo Taniguchi3, Shigeki Momohara3, Soumya Raychaudhuri9, Cornelia F. Allaart10, Hisashi Yamanaka11, Tsuneyo Mimori12 and Fumihiko Matsuda13, 1Departments of Genetics and Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4LUMC, Leiden, Netherlands, 5Department of the Control for Rheumatic Diseases, Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6Dept of Rheum/Clinical Immun, Kyoto University Graduate School of Medicine, Kyoto, Japan, 7Dept of Rheum & Clinical Immun, Kyoto Univ Grad School of Med, Kyoto, Japan, 8Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 9Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 10Rheumatology, LUMC, Leiden, Netherlands, 11Tokyo Women's Medical University, Tokyo, Japan, 12Dept of Rheum & Clinical Immun, Kyoto Univ Grad Schl of Med, Kyoto, Japan, 13Genomic Center, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease leading to joint destruction. Although many studies have addressed correlates associated with the speed of joint destruction,…
  • Abstract Number: 1180 • 2014 ACR/ARHP Annual Meeting

    Dynamic Magnetic Resonance Imaging in the Assessment of the Response to Certolizumab Pegol in Rheumatoid Arthritis Patients: Results from a Phase IIIb Randomized Study

    Mikkel Østergaard1, Mette Bjørndal Axelsen2, Lennart T.H. Jacobsson3, Christopher Schaufelberger3, Michael Sejer Hansen4, Johannes W.J. Bijlsma5, Anna Dudek6, Maria Rell-Bakalarska7, Fabienne Staelens8, Robert Haake9, Britt Sundman-Engberg10 and Henning Bliddal11, 1Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, 2Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Glostrup, Denmark, 3Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 4Department of Rheumatology, Gentofte Hospital, Copenhagen, Denmark, 5Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 6Medica Pro Familia, Warsaw, Poland, 7Rheuma Medicus, Warsaw, Poland, 8UCB Pharma, Brussels, Belgium, 9UCB Pharma, Raleigh, NC, 10UCB Pharma, Stockholm, Sweden, 11The Parker Institute, Department of Rheumatology, Frederiksberg, Denmark

    Background/Purpose Magnetic resonance imaging (MRI) can detect early joint inflammation with high sensitivity, without use of radiation. The MARVELOUS study (NCT01235598), using the OMERACT RA…
  • Abstract Number: 1645 • 2013 ACR/ARHP Annual Meeting

    Circulating CD4+CD161+ T Lymphocytes Are Increased In Seropositive Arthralgia Patients But Decreased In Patients With Newly Diagnosed Rheumatoid Arthritis

    Paulina Chalan1, Bart-Jan Kroesen2, Kornelis S.M. van der Geest1, Minke G. Huitema1, Wayel H. Abdulahad3, Elisabeth Brouwer1 and Annemieke M.H. Boots4, 1Dept. of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Dept. of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 4Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Improved understanding of the immune events discriminating between seropositive arthralgia and clinical synovitis is of key importance in rheumatology research. Ample evidence suggests a…
  • Abstract Number: 1392 • 2013 ACR/ARHP Annual Meeting

    The Expression Of Proto-Oncogene Survivin Splicing Variant 2B In Synovial Tissues and Blood From Patients With Rheumatoid Arthritis

    Sho Mokuda1,2, Tatsuhiko Miyazaki3, Junya Masumoto3, Masamoto Kanno4 and Kiyoshi Takasugi5, 1Department of Immunology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan, 2Department of Internal Medicine, Center for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama, Japan, 3Department of Pathology, Division of Analyticalpathology, Ehime University Graduate School of Medicine, Toon, Japan, 4Department of Immunology, Graduate School of Biomedical Sciences, Hiroshima University, Hirosima, Japan, 5Center for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama, Japan

    Background/Purpose: It has been reported that serum survivin level was an independent risk factor for predicting joint destruction in early rheumatoid arthritis (RA). The proto-oncogene…
  • Abstract Number: 46 • 2012 ACR/ARHP Annual Meeting

    Synovitis in Secondary Osteoarthritis Due to Rheumatoid Arthritis: A Proof-of-Concept Study

    Stefan Vordenbäumen1, Tim Lögters2, Philipp Sewerin1, Thomas Pauly3, Ellen Bleck4, Paulina Philippski1, Matthias Schneider1, Michael Schädel-Höpfner2 and Benedikt Ostendorf1, 1Endocrinology, Diabetology and Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, 2Trauma and Hand Surgery, Heinrich-Heine-University, Düsseldorf, Germany, 3Orthopaedics, Rheinisches Rheumazentrum St. Elisabeth-Hospital, Meerbusch, Germany, 4Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by considerable synovial inflammation which may result in secondary osteoarthritis (sOA). Primary OA (pOA) occurs in patients without predisposing…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology